The results are very significant for reduction of MACE and death from all causes despite not clinically improving the patients' heart failure.
I'd still chalk this up as a win. It just means we still don't understand the mechanism of action, which is fine.
I find it weird they didn't mention GI bleeding? I thought that was something they'd gone on about previously.
All in all better than I expected!
I don't know how this will affect FDA approval. May need more studies? I'd be very surprised if it got approved any time soon to be honest (it's a fairly invasive procedure)
- Forums
- ASX - By Stock
- MSB
- Ann: Mesoblast Phase 3 Chronic Heart Failure Results
Ann: Mesoblast Phase 3 Chronic Heart Failure Results, page-30
-
-
- There are more pages in this discussion • 993 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.01 |
Change
-0.065(6.07%) |
Mkt cap ! $1.147B |
Open | High | Low | Value | Volume |
$1.05 | $1.05 | 99.5¢ | $9.449M | 9.298M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 64999 | $1.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.02 | 64541 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 64999 | 1.005 |
7 | 58759 | 1.000 |
13 | 162397 | 0.995 |
23 | 402743 | 0.990 |
10 | 194198 | 0.985 |
Price($) | Vol. | No. |
---|---|---|
1.020 | 64541 | 3 |
1.025 | 71041 | 4 |
1.030 | 154979 | 5 |
1.035 | 90341 | 5 |
1.040 | 32541 | 1 |
Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online